BUSINESS WIRE; Tuesday, 2 June 1998
It can also prove profitable; for example, more than 40,000 prescriptions for the new drug Viagra were written in just one week. But what process does a drug like Viagra go through before it can be prescribed?
This summer, UC Berkeley Extension will offer professionals and non-scientific professionals in the biotech, pharmaceutical and other health-related industries an opportunity for a greater understanding of the complete drug development process. "An Overview of the Drug Development Process" will take place on Mondays, June 8 - July 13, 6:30 - 9:30 pm, in 8 Sigall Building, Sacred Heart Preparatory Academy, 150 Valparaiso Avenue, Atherton. The fee is $250. Continuing education units are available. To enroll by phone, call 510/642-4111; or visit Extension's website at www.berkeley.edu/unex.
The course will be taught by John Young, Ph.D, and Diane Gordon, Ph.D. Young is a consultant and pharmaceutical executive with more than 28 years of experience in all aspects of market-driven drug development. Gordon, who works with Roche Bioscience, has 15 years of project management experience in the pharmaceutical industry, and holds degrees in pharmacy and pharmaceutical technology.
In a step-by-step approach, Young and Gordon start from the inception of an idea for a new compound and go on through market launch and post-marketing surveillance of the successful product. They discuss the discovery process, preclinical studies, clinical trials, CMC/pharmaceutical development and the regulatory review and approval processes. Students will leave the course with an understanding and appreciation of drug discovery, development and commercial activities as an integrated business process that contributes to the successful advancement of a drug to market. Enrollment is limited.
--30--azs/sf cmf/sf
CONTACT: UC Berkeley Extension Alice Boatwright, 510/643-8093 akb@unx.berkeley.edu
980602
BW980601
Copyright © 1998 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .